PSMA-guided salvage surgery shows PSA decline but limited durable cancer control
Study · Renal & Urology News · 2026-11-10. Number 3 in the UrologyWatch Top 5 for November 11, 2026.
A study of PSMA PET-guided salvage lymph node dissection or metastasectomy reported PSA declines in many patients but limited long-term disease control.
Why it matters: Suggests PSMA-guided salvage surgery may offer short-term biochemical benefit without durable oncologic control in recurrent prostate cancer.
Source: Renal & Urology News
Loading today's edition…